N
Naoual Bakrin
Researcher at Claude Bernard University Lyon 1
Publications - 93
Citations - 2181
Naoual Bakrin is an academic researcher from Claude Bernard University Lyon 1. The author has contributed to research in topics: Hyperthermic intraperitoneal chemotherapy & Ovarian cancer. The author has an hindex of 21, co-authored 91 publications receiving 1578 citations. Previous affiliations of Naoual Bakrin include University of Lyon & Lyon College.
Papers
More filters
Journal ArticleDOI
Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: A French multicentre retrospective cohort study of 566 patients.
Naoual Bakrin,J.M. Bereder,Evelyne Decullier,Jean-Marc Classe,Simon Msika,Gérard Lorimier,Karine Abboud,Pierre Meeus,Gwenael Ferron,François Quenet,Frédéric Marchal,Sebastien Gouy,Philippe Morice,Christophe Pomel,Marc Pocard,Frédéric Guyon,Jack Porcheron,Olivier Glehen +17 more
TL;DR: For advanced and recurrent EOC, curative therapeutic approach combining optimal CRS and HIPEC should be considered as it may achieve long-term survival in patients with a severe prognosis disease, even in patientsWith chemoresistant disease.
Journal ArticleDOI
Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications
Mohammad Alyami,Martin Hübner,Fabian Grass,Fabian Grass,Naoual Bakrin,Laurent Villeneuve,Nathalie Laplace,Guillaume Passot,Olivier Glehen,Vahan Kepenekian +9 more
TL;DR: From the findings, PIPAC has been shown to be feasible and safe and can be considered as a treatment option for refractory, isolated peritoneal metastasis of various origins, however, its use in further indications needs to be validated by prospective studies.
Journal ArticleDOI
What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: A 25-year experience with 1,125 procedures
Guillaume Passot,Delphine Vaudoyer,Laurent Villeneuve,Vahan Kepenekian,Annie Claude Beaujard,Naoual Bakrin,Eddy Cotte,François Noël Gilly,Olivier Glehen +8 more
TL;DR: To review the 25‐year experience with hyperthermic intra‐peritoneal chemotherapy (HIPEC), the authors suggest that conventional chemotherapy should be considered as a best method to treat central giant cell granuloma.
Journal ArticleDOI
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for persistent and recurrent advanced ovarian carcinoma: a multicenter, prospective study of 246 patients.
Naoual Bakrin,Eddy Cotte,François Golfier,F. N. Gilly,Gilles Freyer,W. Helm,Olivier Glehen,J.M. Bereder +7 more
TL;DR: Salvage therapy combining optimal cytoreductive surgery and HIPEC is feasible and may achieve long-term survival in highly selected patients with recurrent ovarian carcinoma, including those with platinum resistant disease, with acceptable morbidity.
Journal ArticleDOI
Multicentric initial experience with the use of the pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the management of unresectable peritoneal carcinomatosis.
Mohammad Alyami,Johan Gagnière,Olivia Sgarbura,Delphine Cabelguenne,Laurent Villeneuve,Denis Pezet,François Quenet,Olivier Glehen,Naoual Bakrin,Guillaume Passot +9 more
TL;DR: Implementing a PIPAC program in association with systemic chemotherapy is feasible and is associated with a risk of postoperative morbidity, even in teams highly experienced in PC management and requires a learning curve in patient selection.